These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30274532)

  • 1. Contribution assessment of multiparameter optimization descriptors in CNS penetration.
    Raevsky OA; Grigorev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    SAR QSAR Environ Res; 2018 Oct; 29(10):785-800. PubMed ID: 30274532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the classification abilities of the CNS multi-parametric optimization approach by the method of logistic regression.
    Raevsky OA; Polianczyk DE; Mukhametov A; Grigorev VY
    SAR QSAR Environ Res; 2016 Aug; 27(8):629-35. PubMed ID: 27477321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2010 Jun; 1(6):435-49. PubMed ID: 22778837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical property profile for brain permeability: comparative study by different approaches.
    Raevsky OA; Grigorev VY; Polianczyk DE; Sandakov GI; Solodova SL; Yarkov AV; Bachurin SO; Dearden JC
    J Drug Target; 2016 Aug; 24(7):655-62. PubMed ID: 26755431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technically Extended MultiParameter Optimization (TEMPO): An Advanced Robust Scoring Scheme To Calculate Central Nervous System Druggability and Monitor Lead Optimization.
    Ghose AK; Ott GR; Hudkins RL
    ACS Chem Neurosci; 2017 Jan; 8(1):147-154. PubMed ID: 27741392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification models of structure - P-glycoprotein activity of drugs].
    Grigorev VY; Solodova SL; Polianczyk DE; Raevsky OA
    Biomed Khim; 2016; 62(2):173-9. PubMed ID: 27143376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS Multiparameter Optimization Approach: Is it in Accordance with Occam's Razor Principle?
    Raevsky OA
    Mol Inform; 2016 Apr; 35(3-4):94-8. PubMed ID: 27491918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six global and local QSPR models of aqueous solubility at pH = 7.4 based on structural similarity and physicochemical descriptors.
    Raevsky OA; Grigorev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    SAR QSAR Environ Res; 2017 Aug; 28(8):661-676. PubMed ID: 28891683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of blood-brain penetration using structural descriptors.
    Katritzky AR; Kuanar M; Slavov S; Dobchev DA; Fara DC; Karelson M; Acree WE; Solov'ev VP; Varnek A
    Bioorg Med Chem; 2006 Jul; 14(14):4888-917. PubMed ID: 16697202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational models to predict blood-brain barrier permeation and CNS activity.
    Subramanian G; Kitchen DB
    J Comput Aided Mol Des; 2003 Oct; 17(10):643-64. PubMed ID: 15068364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier permeability mechanisms in view of quantitative structure-activity relationships (QSAR).
    Bujak R; Struck-Lewicka W; Kaliszan M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015 Apr; 108():29-37. PubMed ID: 25703237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2016 Jun; 7(6):767-75. PubMed ID: 26991242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive model of blood-brain barrier penetration of organic compounds.
    Ma XL; Chen C; Yang J
    Acta Pharmacol Sin; 2005 Apr; 26(4):500-12. PubMed ID: 15780201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the Pfizer Central Nervous System Multiparameter Optimization Calculator and a BBB Machine Learning Model.
    Urbina F; Zorn KM; Brunner D; Ekins S
    ACS Chem Neurosci; 2021 Jun; 12(12):2247-2253. PubMed ID: 34028255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Genetic Algorithm Based Support Vector Machine Model for Blood-Brain Barrier Penetration Prediction.
    Zhang D; Xiao J; Zhou N; Zheng M; Luo X; Jiang H; Chen K
    Biomed Res Int; 2015; 2015():292683. PubMed ID: 26504797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
    Jiang L; Chen J; He Y; Zhang Y; Li G
    J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-silico prediction of blood-brain barrier permeability.
    Yan A; Liang H; Chong Y; Nie X; Yu C
    SAR QSAR Environ Res; 2013 Jan; 24(1):61-74. PubMed ID: 23092117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADME properties evaluation in drug discovery: in silico prediction of blood-brain partitioning.
    Zhu L; Zhao J; Zhang Y; Zhou W; Yin L; Wang Y; Fan Y; Chen Y; Liu H
    Mol Divers; 2018 Nov; 22(4):979-990. PubMed ID: 30083853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.